Review



p38mapk thr180 tyr182 phosphorylation  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Cell Signaling Technology Inc p38mapk thr180 tyr182 phosphorylation
    <t>LKB1-p38</t> <t>MAPK</t> signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of <t>p38MAPK</t> phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).
    P38mapk Thr180 Tyr182 Phosphorylation, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 6257 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38mapk thr180 tyr182 phosphorylation/product/Cell Signaling Technology Inc
    Average 99 stars, based on 6257 article reviews
    p38mapk thr180 tyr182 phosphorylation - by Bioz Stars, 2026-02
    99/100 stars

    Images

    1) Product Images from "The hydroxamate based HDAC inhibitor WMJ-J-09 induces colorectal cancer cell death by targeting tubulin and downregulating survivin"

    Article Title: The hydroxamate based HDAC inhibitor WMJ-J-09 induces colorectal cancer cell death by targeting tubulin and downregulating survivin

    Journal: Scientific Reports

    doi: 10.1038/s41598-025-04714-w

    LKB1-p38 MAPK signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of p38MAPK phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).
    Figure Legend Snippet: LKB1-p38 MAPK signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of p38MAPK phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).

    Techniques Used: Western Blot, Phospho-proteomics, Expressing, Negative Control, Control



    Similar Products

    99
    Cell Signaling Technology Inc p38mapk thr180 tyr182 phosphorylation
    <t>LKB1-p38</t> <t>MAPK</t> signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of <t>p38MAPK</t> phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).
    P38mapk Thr180 Tyr182 Phosphorylation, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38mapk thr180 tyr182 phosphorylation/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    p38mapk thr180 tyr182 phosphorylation - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    90
    ImmunoWay Biotechnology Company anti-p38mapk phosphorylation antibody
    <t>LKB1-p38</t> <t>MAPK</t> signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of <t>p38MAPK</t> phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).
    Anti P38mapk Phosphorylation Antibody, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-p38mapk phosphorylation antibody/product/ImmunoWay Biotechnology Company
    Average 90 stars, based on 1 article reviews
    anti-p38mapk phosphorylation antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Servicebio Inc anti-phosphorylated p38mapk
    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated <t>p38MAPK</t> (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Anti Phosphorylated P38mapk, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-phosphorylated p38mapk/product/Servicebio Inc
    Average 90 stars, based on 1 article reviews
    anti-phosphorylated p38mapk - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc phosphorylated p p38mapk
    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated <t>p38MAPK</t> (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Phosphorylated P P38mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated p p38mapk/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    phosphorylated p p38mapk - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc anti phosphorylated p38mapk
    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated <t>p38MAPK</t> (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Anti Phosphorylated P38mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phosphorylated p38mapk/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    anti phosphorylated p38mapk - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc phosphorylated p38mapk
    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated <t>p38MAPK</t> (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Phosphorylated P38mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated p38mapk/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    phosphorylated p38mapk - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc p38mapk phosphorylated at thr180 and tyr182 (1/1000, #4511)
    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated <t>p38MAPK</t> (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
    P38mapk Phosphorylated At Thr180 And Tyr182 (1/1000, #4511), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38mapk phosphorylated at thr180 and tyr182 (1/1000, #4511)/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    p38mapk phosphorylated at thr180 and tyr182 (1/1000, #4511) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc phosphorylated-mitogen-activated protein kinase p38 p-p38mapk 4511 antibody
    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated <t>p38MAPK</t> (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Phosphorylated Mitogen Activated Protein Kinase P38 P P38mapk 4511 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated-mitogen-activated protein kinase p38 p-p38mapk 4511 antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    phosphorylated-mitogen-activated protein kinase p38 p-p38mapk 4511 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    LKB1-p38 MAPK signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of p38MAPK phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).

    Journal: Scientific Reports

    Article Title: The hydroxamate based HDAC inhibitor WMJ-J-09 induces colorectal cancer cell death by targeting tubulin and downregulating survivin

    doi: 10.1038/s41598-025-04714-w

    Figure Lengend Snippet: LKB1-p38 MAPK signaling contributed to WMJ-J-09-mediated p21 and survivin regulation. ( A ) Immunoblot result of p38MAPK phosphorylation in HCT116 cells exposed to WMJ-J-09. ( B , C ) Immunoblot result of p21 ( B ) and survivin ( C ) expression in WMJ-J-09-stimulated HCT116 cells with or without p38 inhibitor III ( D ) Immunoblot result of LKB1 phosphorylation in HCT116 cells exposed to WMJ-J-09 for indicated periods. ( E ) Immunoblot results from the effects of LKB1 siRNA or negative control siRNA on p38MAPK and p53 phosphorylation elicited by WMJ-J-09. ( F ) Immunoblot result of the effects of LKB1 siRNA or negative control siRNA on WMJ-J-09-modulated p21 and survivin expression in HCT116 cells. Each band intensity was quantified, and total α-tubulin levels normalized the fold changes of LKB1, p21, and survivin; total p53 levels normalized that of p53 phosphorylation; total p38MAPK levels normalized that of p38MAPK phosphorylation; total LKB1 levels normalized that of LKB1 phosphorylation. Error bars, mean ± S.E.M. (shown only for independent replicate experiments with n ≥ 4). One-way ANOVA followed by Tukey’s post-hoc test assessed statistical significance (*p < 0.05 compared to the control group).

    Article Snippet: Antibodies against α-tubulin Lys40 acetylation, p53, p53 Lys379 acetylation, p53 Ser15 phosphorylation, p38MAPK Thr180/Tyr182 phosphorylation, p38MAPK, LKB1, LKB1 Ser428 phosphorylation, PARP, cleaved caspase 3 (active form) and survivin were from Cell Signaling (Danvers, MA, U.S.A.).

    Techniques: Western Blot, Phospho-proteomics, Expressing, Negative Control, Control

    Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated p38MAPK (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Scientific Reports

    Article Title: The pro-tumor activity of INTS7 on lung adenocarcinoma via inhibiting immune infiltration and activating p38MAPK pathway

    doi: 10.1038/s41598-024-77093-3

    Figure Lengend Snippet: Potential mechanisms involved in the regulatory activity of INTS7. (A) Immunohistochemical staining and statistical analysis of INTS7 in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (B) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in clinical tumor tissues ( n = 6, Low = Group with low INTS7 expression, High = Group with high INTS7 expression, scale bar: 50 μm). (C) H&E staining of xenograft tumor tissues (scale bar: 50 μm). (D) Immunohistochemical staining and statistical analysis of INTS7 in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (E) Immunohistochemical staining and statistical analysis of cleaved caspase-3 (c-caspase-3) in xenograft tumor tissues ( n = 5, scale bar: 50 μm). (F) Expression of INTS7 by western blot analysis ( n = 3). (G) Expression of cleaved caspase-3 (c-caspase-3), p53, phosphorylated p38MAPK (p-p38MAPK) and MMP2 by western blot analysis ( n = 3, respectively). The grouping of blots were cropped from different parts of the same gel. Original images of blots are presented in Supplementary Figs. 2–6). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% bovine serum albumin (BSA) and incubated overnight at 4 ℃ with the following primary antibodies: anti-INTS7 (1:1000, Proteintech, USA), anti-cleaved caspase-3 (1:1000, Proteintech, USA), anti-p53 (1:500, Proteintech, USA), anti-p38MAPK (1:1000, Servicebio, China), anti-phosphorylated p38MAPK (1:1000, Servicebio, China), anti-MMP2 (1:1000, Servicebio, China). β-actin (1:5000, Proteintech, USA) was used as loading control.

    Techniques: Activity Assay, Immunohistochemical staining, Staining, Expressing, Western Blot